Keurig Dr Pepper, Nestle USA extend Starbucks K-Cup partnership
Get Alerts KDP Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3%
Revenue Growth %: +74.3%
Join SI Premium – FREE
Keurig Dr Pepper (NASDAQ: KDP) and Nestle USA announced an extended agreement renewing their strategic partnership for manufacturing and distributing Starbucks K-Cup pods in the United States and Canada.
The agreement builds on a collaboration first established in 2020 and includes new programs focused on expanding distribution and innovation for the Starbucks brand in the Keurig brewing system. Under Nestle's global agreement with Starbucks for consumer packaged goods, Nestle handles distribution of Starbucks at-home coffee platforms into grocery and other retail channels outside of Starbucks coffeehouses, excluding ready-to-drink products.
"Keurig's leading single-serve coffee platform is built on great brands and strong partnerships," said Olivier Lemire, President, U.S. Coffee at Keurig Dr Pepper. "We look forward to deepening our relationship with Nestle to build upon our long-standing partnership with Starbucks, one of the most beloved brands within the Keurig system."
"The Keurig system is an important platform for our Starbucks at-home portfolio and we are pleased to renew our agreement, as we look to build upon our K-Cup pod innovation and offerings for consumers," said Daniel Jhung, President of Nestle USA Coffee & Beverage Division.
The Starbucks K-Cup pods feature premium Arabica coffee sourced and roasted by Starbucks, offering consumers a range of signature blends, roasts, and flavored coffees that can be prepared hot or iced through the Keurig brewing system.
Keurig Dr Pepper operates a global coffee business spanning more than 100 markets and includes the Keurig single-serve brewing system in the U.S. and Canada, along with brands such as Peet's, L'OR and Jacobs.
You May Also Be Interested In
- A.O. Smith executive chairman to retire, CEO to assume chairman role
- MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
- Avis Budget Group reaches $650M settlement with Pentwater Capital
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share